{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:48:54Z","timestamp":1789728534645,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Ministry of Science and Technology, Executive Yuan, Taiwan","award":["MOST-105-2628-B-195-001-MY3"],"award-info":[{"award-number":["MOST-105-2628-B-195-001-MY3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0883-6","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:37:50Z","timestamp":1535557070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA"],"prefix":"10.1186","volume":"13","author":[{"given":"Hsiang-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Miao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Lieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kuang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"883_CR1","unstructured":"Neufeld EF, Muenzer J: The mucoplysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill; 2001, 3421\u20133452."},{"issue":"Suppl 5","key":"883_CR2","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","volume":"50","author":"J Muenzer","year":"2011","unstructured":"Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011;50(Suppl 5):v4\u201312.","journal-title":"Rheumatology (Oxford)"},{"key":"883_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF01991908","volume":"154","author":"CF Wippermann","year":"1995","unstructured":"Wippermann CF, Beck M, Schranz D, Huth R, Michel-Behnke I, J\u00fcngst BK. Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur J Pediatr. 1995;154:98\u2013101.","journal-title":"Eur J Pediatr"},{"key":"883_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1651-2227.2002.tb03330.x","volume":"91","author":"UR Mohan","year":"2002","unstructured":"Mohan UR, Hay AA, Cleary MA, Wraith JE, Patel RG. Cardiovascular changes in children with mucopolysaccharide disorders. Acta Paediatr. 2002;91:799\u2013804.","journal-title":"Acta Paediatr"},{"key":"883_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2143\/AC.60.1.2005049","volume":"60","author":"MR Chen","year":"2005","unstructured":"Chen MR, Lin SP, Hwang HK, Yu CH. Cardiovascular changes in mucopolysaccharidoses in Taiwan. Acta Cardiol. 2005;60:51\u20133.","journal-title":"Acta Cardiol"},{"key":"883_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1017\/S104795110999062X","volume":"20","author":"GN Leal","year":"2010","unstructured":"Leal GN, de Paula AC, Leone C, Kim CA. Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol Young. 2010;20:254\u201361.","journal-title":"Cardiol Young"},{"key":"883_CR7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","volume":"34","author":"EA Braunlin","year":"2011","unstructured":"Braunlin EA, Harmatz PR, Scarpa M, Furlanetto B, Kampmann C, Loehr JP, et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011;34:1183\u201397.","journal-title":"J Inherit Metab Dis"},{"key":"883_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10545-011-9444-z","volume":"36","author":"MM Brands","year":"2013","unstructured":"Brands MM, Frohn-Mulder IM, Hagemans ML, Hop WC, Oussoren E, Helbing WA, et al. Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI. J Inherit Metab Dis. 2013;36:227\u201334.","journal-title":"J Inherit Metab Dis"},{"key":"883_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ymgme.2014.02.009","volume":"111","author":"SM Lin","year":"2014","unstructured":"Lin SM, Lin HY, Chuang CK, Lin SP, Chen MR. Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis. Mol Genet Metab. 2014;111:493\u20138.","journal-title":"Mol Genet Metab"},{"key":"883_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ymgme.2016.02.003","volume":"117","author":"HY Lin","year":"2016","unstructured":"Lin HY, Chuang CK, Chen MR, Lin SM, Hung CL, Chang CY, et al. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI. Mol Genet Metab. 2016;117:431\u20137.","journal-title":"Mol Genet Metab"},{"key":"883_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","volume":"98","author":"EA Braunlin","year":"2006","unstructured":"Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol. 2006;98:416\u20138.","journal-title":"Am J Cardiol"},{"key":"883_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","volume":"32","author":"SA Jones","year":"2009","unstructured":"Jones SA, Alm\u00e1ssy Z, Beck M, Burt K, Clarke JT, Giugliani R, et al. Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the hunter outcome survey (HOS). J Inherit Metab Dis. 2009;32:534\u201343.","journal-title":"J Inherit Metab Dis"},{"key":"883_CR13","first-page":"59","volume":"15","author":"C Lavery","year":"2015","unstructured":"Lavery C, Hendriksz C. Mortality in patients with Morquio syndrome a. JIMD Rep. 2015;15:59\u201366.","journal-title":"JIMD Rep"},{"key":"883_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-016-0471-6","volume":"11","author":"HY Lin","year":"2016","unstructured":"Lin HY, Chuang CK, Huang YH, Tu RY, Lin FJ, Lin SJ, et al. Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012. Orphanet J Rare Dis. 2016;11:85.","journal-title":"Orphanet J Rare Dis"},{"key":"883_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-9-21","volume":"9","author":"HY Lin","year":"2014","unstructured":"Lin HY, Chuang CK, Chen MR, Chiu PC, Ke YY, Niu DM, et al. Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA. Orphanet J Rare Dis. 2014;9:21.","journal-title":"Orphanet J Rare Dis"},{"key":"883_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162612","volume":"11","author":"C Kampmann","year":"2016","unstructured":"Kampmann C, Abu-Tair T, G\u00f6kce S, Lampe C, Reinke J, Mengel E, et al. Heart and cardiovascular involvement in patients with Mucopolysaccharidosis type IVA (Morquio-a syndrome). PLoS One. 2016;11:e0162612.","journal-title":"PLoS One"},{"key":"883_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/adc.65.7.746","volume":"65","author":"RM John","year":"1990","unstructured":"John RM, Hunter D, Swanton RH. Echocardiographic abnormalities in type IV mucopolysaccharidosis. Arch Dis Child. 1990;65:746\u20139.","journal-title":"Arch Dis Child"},{"key":"883_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/hrt.46.1.113","volume":"46","author":"MA Ireland","year":"1981","unstructured":"Ireland MA, Rowlands DB. Mucopolysaccharidosis type IV as a cause of mitral stenosis in an adult. Br Heart J. 1981;46:113\u20135.","journal-title":"Br Heart J"},{"key":"883_CR19","doi-asserted-by":"publisher","first-page":"E96","DOI":"10.1532\/HSF98.20071197","volume":"11","author":"F Nicolini","year":"2008","unstructured":"Nicolini F, Corradi D, Bosio S, Gherli T. Aortic valve replacement in a patient with morquio syndrome. Heart Surg Forum. 2008;11:E96\u20138.","journal-title":"Heart Surg Forum"},{"key":"883_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1053\/j.jvca.2008.12.009","volume":"23","author":"PS Pagel","year":"2009","unstructured":"Pagel PS, Almassi GH. Perioperative implications of Morquio syndrome in a 31-year-old woman undergoing aortic valve replacement. J Cardiothorac Vasc Anesth. 2009;23:855\u20137.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"883_CR21","first-page":"839","volume":"15","author":"MO Barry","year":"2006","unstructured":"Barry MO, Beardslee MA, Braverman AC. Morquio's syndrome: severe aortic regurgitation and late pulmonary autograft failure. J Heart Valve Dis. 2006;15:839\u201342.","journal-title":"J Heart Valve Dis"},{"key":"883_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","volume":"37","author":"CJ Hendriksz","year":"2014","unstructured":"Hendriksz CJ, Burton B, Fleming TR, Harmatz P, Hughes D, Jones SA, et al. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio a syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J Inherit Metab Dis. 2014;37:979\u201390.","journal-title":"J Inherit Metab Dis"},{"key":"883_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ymgme.2016.05.018","volume":"119","author":"CJ Hendriksz","year":"2016","unstructured":"Hendriksz CJ, Parini R, AlSayed MD, Raiman J, Giugliani R, Solano Villarreal ML, et al. Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio a syndrome. Mol Genet Metab. 2016;119:131\u201343.","journal-title":"Mol Genet Metab"},{"key":"883_CR24","first-page":"15","volume":"64","author":"CK Chuang","year":"2001","unstructured":"Chuang CK, Lin SP, Chung SF. Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis. Zhonghua Yi Xue Za Zhi (Taipei). 2001;64:15\u201322.","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"883_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","volume":"37","author":"LE Teichholz","year":"1976","unstructured":"Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976;37:7\u201311.","journal-title":"Am J Cardiol"},{"key":"883_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.echo.2003.12.005","volume":"17","author":"BW Eidem","year":"2004","unstructured":"Eidem BW, McMahon CJ, Cohen RR, Wu J, Finkelshteyn I, Kovalchin JP, et al. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. J Am Soc Echocardiogr. 2004;17:212\u201321.","journal-title":"J Am Soc Echocardiogr"},{"key":"883_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","volume":"22","author":"H Baumgartner","year":"2009","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1\u201323. quiz 101-102.","journal-title":"J Am Soc Echocardiogr"},{"key":"883_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ehjci\/jet105","volume":"14","author":"P Lancellotti","year":"2013","unstructured":"Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14:611\u201344.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"883_CR29","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"883_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/0002-9149(88)90971-X","volume":"62","author":"Y Sahasakul","year":"1988","unstructured":"Sahasakul Y, Edwards WD, Naessens JM, Tajik AJ. Age-related changes in aortic and mitral valve thickness: implications for two-dimensional echocardiography based on an autopsy study of 200 normal human hearts. Am J Cardiol. 1988;62:424\u201330.","journal-title":"Am J Cardiol"},{"key":"883_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/heart.83.6.667","volume":"83","author":"C Kampmann","year":"2000","unstructured":"Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in Central Europe. Heart. 2000;83:667\u201372.","journal-title":"Heart"},{"key":"883_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00246-006-0101-5","volume":"28","author":"T Poutanen","year":"2007","unstructured":"Poutanen T, Jokinen E. Left ventricular mass in 169 healthy children and young adults assessed by three-dimensional echocardiography. Pediatr Cardiol. 2007;28:201\u20137.","journal-title":"Pediatr Cardiol"},{"key":"883_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","volume":"110","author":"CJ Hendriksz","year":"2013","unstructured":"Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, et al. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab. 2013;110:54\u201364.","journal-title":"Mol Genet Metab"},{"key":"883_CR34","doi-asserted-by":"crossref","unstructured":"Bolourchi M, Renella P, Wang RY. Aortic Root Dilatation in Mucopolysaccharidosis I-VII. Int J Mol Sci. 2016;17(12):E2004.","DOI":"10.3390\/ijms17122004"},{"key":"883_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1542\/peds.2006-2184","volume":"120","author":"R Giugliani","year":"2007","unstructured":"Giugliani R, Harmatz P, Wraith JE. Management guidelines for mucopolysaccharidosis VI. Pediatrics. 2007;120:405\u201318.","journal-title":"Pediatrics"},{"key":"883_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1542\/peds.2008-0416","volume":"123","author":"J Muenzer","year":"2009","unstructured":"Muenzer J, Wraith JE, Clarke LA. International consensus panel on management and treatment of Mucopolysaccharidosis I: Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics. 2009;123:19\u201329.","journal-title":"Pediatrics"},{"key":"883_CR37","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1542\/peds.2006-2156","volume":"120","author":"JE Wraith","year":"2007","unstructured":"Wraith JE, Beck M, Lane R, van der Ploeg A, Shapiro E, Xue Y, et al. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). Pediatrics. 2007;120:e37\u201346.","journal-title":"Pediatrics"},{"key":"883_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1017\/S1047951109003576","volume":"19","author":"V Fesslov\u00e1","year":"2009","unstructured":"Fesslov\u00e1 V, Corti P, Sersale G, Rovelli A, Russo P, Mannarino S, et al. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young. 2009;19:170\u20138.","journal-title":"Cardiol Young"},{"key":"883_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10545-012-9481-2","volume":"36","author":"E Braunlin","year":"2013","unstructured":"Braunlin E, Rosenfeld H, Kampmann C, Johnson J, Beck M, Giugliani R, et al. Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme\u00ae) therapy. J Inherit Metab Dis. 2013;36:385\u201394.","journal-title":"J Inherit Metab Dis"},{"key":"883_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10545-013-9649-4","volume":"37","author":"C Kampmann","year":"2014","unstructured":"Kampmann C, Lampe C, Whybra-Tr\u00fcmpler C, Wiethoff CM, Mengel E, Arash L, et al. Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy. J Inherit Metab Dis. 2014;37:269\u201376.","journal-title":"J Inherit Metab Dis"},{"key":"883_CR41","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1542\/peds.2009-1728","volume":"125","author":"O Gabrielli","year":"2010","unstructured":"Gabrielli O, Clarke LA, Bruni S, Coppa GV. Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up. Pediatrics. 2010;125:e183\u20137.","journal-title":"Pediatrics"},{"key":"883_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","volume":"77","author":"JJ McGill","year":"2010","unstructured":"McGill JJ, Inwood AC, Coman DJ, Lipke ML, de Lore D, Swiedler SJ, et al. Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age--a sibling control study. Clin Genet. 2010;77:492\u20138.","journal-title":"Clin Genet"},{"key":"883_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymgmr.2017.08.007","volume":"13","author":"M Furujo","year":"2017","unstructured":"Furujo M, Kosuga M, Okuyama T. Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI: 10-year follow up. Mol Genet Metab Rep. 2017;13:69\u201375.","journal-title":"Mol Genet Metab Rep"},{"key":"883_CR44","doi-asserted-by":"publisher","unstructured":"Franco JF, Soares DC, Torres LC, Leal GN, Cunha MT, Honjo RS, et al. Short Communication Impact of early enzyme-replacement therapy for mucopolysaccharidosis VI: results of a long-term follow-up of Brazilian siblings. Genet Mol Res. 2016;15(1). \n                    https:\/\/doi.org\/10.4238\/gmr.15017850\n                    \n                  .","DOI":"10.4238\/gmr.15017850"},{"key":"883_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-015-0344-4","volume":"10","author":"NA Al-Sannaa","year":"2015","unstructured":"Al-Sannaa NA, Bay L, Barbouth DS, Benhayoun Y, Goizet C, Guelbert N, et al. Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships. Orphanet J Rare Dis. 2015;10:131.","journal-title":"Orphanet J Rare Dis"},{"key":"883_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1750-1172-8-147","volume":"8","author":"SP Lin","year":"2013","unstructured":"Lin SP, Lin HY, Wang TJ, Chang CY, Lin CH, Huang SF, et al. A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan. Orphanet J Rare Dis. 2013;8:147.","journal-title":"Orphanet J Rare Dis"},{"key":"883_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13023-018-0816-4","volume":"13","author":"CK Chuang","year":"2018","unstructured":"Chuang CK, Lin HY, Wang TJ, Huang YH, Chan MJ, Liao HC, et al. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan. Orphanet J Rare Dis. 2018;13:84.","journal-title":"Orphanet J Rare Dis"},{"key":"883_CR48","doi-asserted-by":"publisher","first-page":"e6887","DOI":"10.1097\/MD.0000000000006887","volume":"96","author":"C Col\u00f3n","year":"2017","unstructured":"Col\u00f3n C, Alvarez JV, Casta\u00f1o C, Gutierrez-Solana LG, Marquez AM, O'Callaghan M, et al. A selective screening program for the early detection of mucopolysaccharidosis: results of the FIND project - a 2-year follow-up study. Medicine (Baltimore). 2017;96:e6887.","journal-title":"Medicine (Baltimore)"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0883-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T23:07:46Z","timestamp":1567033666000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0883-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0883-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"16 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki of 1975, as revised in 2000. The Institutional Review Board of Mackay Memorial Hospital approved this study, and written informed consent was obtained from all of the patients or their parents who were included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all of the patients or their parents who were included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"148"}}